15 insiders reported 69 Form 4 transactions for Pacira BioSciences, Inc. (PCRX) over the past 18 months (most recent 2026-06-12). Recent activity: Brege Laura (Director) Buy 6,405 shares, RIKER LAUREN (Senior Vice President, Finance) Sell 6,115 shares, YANG MICHAEL J. (Director) Buy 6,405 shares, Froimson Mark (Director) Buy 6,405 shares, Hirawat Samit (Director) Buy 6,405 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Brege Laura | Director | Buy | 6,405 | $0 |
| 2026-06-12 | RIKER LAUREN | Senior Vice President, Finance | Sell | 6,115 | $143,702 |
| 2026-06-12 | YANG MICHAEL J. | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Froimson Mark | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Hirawat Samit | Director | Buy | 6,405 | $0 |
| 2026-06-12 | CHRISTIE CHRISTOPHER | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Young Alethia | Director | Buy | 6,405 | $0 |
| 2026-06-12 | BIGAL MARCELO | Director | Buy | 6,405 | $0 |
| 2026-06-05 | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 8,528 | $190,345 |
| 2026-06-05 | RIKER LAUREN | Senior Vice President, Finance | Sell | 3,187 | $71,134 |
| 2026-06-05 | SLONIN JONATHAN | Chief Medical Officer | Sell | 4,728 | $105,529 |
| 2026-06-05 | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 10,259 | $228,468 |
| 2026-04-24 | Cross Shawn | Chief Financial Officer | Buy | 12,941 | $212,879 |
| 2026-04-24 | Cross Shawn | Chief Financial Officer | Sell | 12,941 | $325,596 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Buy | 7,714 | $126,895 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Sell | 7,714 | $193,930 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Buy | 2,845 | $46,800 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Sell | 2,845 | $71,153 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Buy | 1,500 | $24,675 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Sell | 1,500 | $37,515 |
| 2026-03-19 | Kronenfeld Mark A. | Director | Buy | 6,163 | $0 |
| 2026-03-19 | Froimson Mark | Director | Sell | 500 | $10,905 |
| 2026-03-19 | SLONIN JONATHAN | Chief Medical Officer | Sell | 3,261 | $74,416 |
| 2026-02-13 | Teehan Brendan | Chief Commercial Officer | Buy | 51,714 | $0 |
| 2026-02-13 | Lee Frank D. | Chief Executive Officer | Buy | 261,818 | $0 |
Source: SEC Form 4 filings · as of 2026-06-12